Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Institut D'Optique Theorique Et Appliquee has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. Both of these matters are assigned to 1 distinct examiner, MONTANARI, DAVID A. This individual is the busiest examiner for the portfolio, handling 2 pending cases within 1 distinct art unit.
The consolidation of 2 pending office actions under 1 distinct examiner creates a focused prosecution environment. MONTANARI, DAVID A is the sole decision-maker for the current active portfolio, meaning that the company's success in the Biotechnology & Pharmaceuticals field depends on this relationship. This arrangement allows for a unified strategy where arguments can be consistently applied.
With 1 distinct art unit involved, the technical standards and prior art being applied to the 2 pending office actions are likely to be very similar. MONTANARI, DAVID A manages 2 pending cases, which may allow for procedural efficiencies as the examiner becomes familiar with the company's technology. Practitioners should focus on the specific examination history of this 1 distinct examiner to resolve the pending cases effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTANARI, DAVID A | 2 | 64.8% | +49.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18374889 | CELLULAR MICROCOMPARTMENT AND PREPARATION PROCESSES | MONTANARI, DAVID A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18916118 | CELLULAR MICROCOMPARTMENT AND PREPARATION PROCESSES | MONTANARI, DAVID A | — |
| 18374889 | CELLULAR MICROCOMPARTMENT AND PREPARATION PROCESSES | MONTANARI, DAVID A | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18916118 | CELLULAR MICROCOMPARTMENT AND PREPARATION PROCESSES | MONTANARI, DAVID A | 1632 | DP | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18374889 | CELLULAR MICROCOMPARTMENT AND PREPARATION PROCESSES | MONTANARI, DAVID A | 1632 | §103§112Other | Non-Final OA | — | Pending | Sep 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitut D'Optique Theorique Et Appliquee has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
David A Montanari has the most, with 2 of Institut D'Optique Theorique Et Appliquee's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
